1-7 of 7
Naveen Premnath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II clinical trial of bortezomib in combination with CPX-351 for the treatment of newly-diagnosed TP53-mutated Acute Myeloid Leukemia (NCT07008638)

Free
Joseph Norton, Nuttavut Sumransub, Kieth Cordner, Jeremy Allred, Naveen Premnath, Sean Tracy, Craig Eckfeldt, Qing Cao, Mark Juckett, Veronika Bachanova, Zohar Sachs
Journal: Blood
Blood (2025) 146 (Supplement 1): 3433.
https://doi.org/10.1182/blood-2025-3433
Published: 2025
Journal Articles

Gtb-3650 (anti-CD16/IL-15/anti-CD33) tri-specific killer engager (TriKE®) for the treatment of high risk myelodysplastic syndromes (MDS) and refractory/relapsed (R/R) Acute Myeloid Leukemia (AML) (NCT06594445)

Free
Mark Juckett, Christopher Graham, Punita Grover, Joseph Norton, Naveen Premnath, Craig Eckfeldt, Zohar Sachs, Cassie Seichter, Andrea Hoeschen, Cameron McDonald-Hyman, Jeremy Allred, Rose Wangen, Martin Felices, Jeffrey Miller
Journal: Blood
Blood (2025) 146 (Supplement 1): 6947.
https://doi.org/10.1182/blood-2025-6947
Published: 2025
Journal Articles

Clonal Hematopoiesis and Heart Failure with Preserved Ejection Fraction

Free
Toby Thomas, Yuanyuan Ji, Fatma Kalkan, Albert Son, Ambarish Pandey, Vinayak Subramanian, Naveen Premnath, Michalis Agathocleous, Qing Ding, Alexander G. Bick, Benjamin Kroger, Dan Tong, Stephen S. Chung
Journal: Blood
Blood (2022) 140 (Supplement 1): 8611–8612.
https://doi.org/10.1182/blood-2022-171138
Published: 2022
Journal Articles

Post-Transplant Cyclophosphamide Associated with Increased Early Mixed Donor Chimerism in Myeloid Malignancies; A Single-Center Experience

Free
Fieke W. Hoff, Prapti A. Patel, Stephen S. Chung, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Jaime Shahan, Courtney Dryden, Hetalkumari Patel, Afrough Aimaz, Praveen Ramakrishnan Geethakumari, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat
Journal: Blood
Blood (2022) 140 (Supplement 1): 4749–4750.
https://doi.org/10.1182/blood-2022-166756
Published: 2022
Journal Articles

Racial and Ethnic Disparities in Acute Myeloid Leukemia: 15-Year Experience at a Safety-Net Health System

Free
Sharlene Dong, Naveen Premnath, Navid Sadeghi, Radhika Kainthla, Stephen S. Chung, Madhuri Vusirikala, Robert H. Collins, Hsiao C. Li, Yazan F. Madanat
Journal: Blood
Blood (2022) 140 (Supplement 1): 3194–3195.
https://doi.org/10.1182/blood-2022-165285
Published: 2022
Journal Articles

COVID Vaccine Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Better Antibody Response in Patients with Myeloid Malignancies Than B-Cell Malignancies

Free
Suleyman Y Goksu, John Rolwes, Naveen Premnath, Prapti Patel, Ruth Ikpefan, Gurbakhash Kaur, Madhuri Vusirikala, Taha Bat, Weina Chen, Praveen Ramakrishnan, Ankit Kansagra, Larry D. Anderson, Jr., Farrukh T. Awan, Robert H. Collins, Stephen Chung, Yazan F. Madanat
Journal: Blood
Blood (2021) 138 (Supplement 1): 4134.
https://doi.org/10.1182/blood-2021-152930
Published: 2021
Journal Articles

Clinical and Molecular Characteristics Associated with Vitamin C Deficiency in Myeloid Malignancies; Real World Data from a Prospective Cohort

Free
Naveen Premnath, Stephen Chung, Suleyman Y Goksu, Prapti Patel, Ruth Ikpefan, John Rolwes, Mohak Pandey, Gurbakhash Kaur, Praveen Ramakrishnan, Ankit Kansagra, Farrukh T. Awan, Larry D. Anderson, Jr., Madhuri Vusirikala, Robert H. Collins, Michalis Agathocleous, Yazan F. Madanat
Journal: Blood
Blood (2021) 138 (Supplement 1): 1217.
https://doi.org/10.1182/blood-2021-149753
Published: 2021